Inventor
SERRADEIL-LE GAL CLAUDINE
FR24 patents
⚠️ This page may combine multiple inventors who share the name “SERRADEIL-LE GAL CLAUDINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS
9 patentsUS7119086B2Oct 10, 2006
Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
SANOFI AVENTIS52 citations92
US7968534B2Jun 28, 2011
Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors
SANOFI AVENTIS7 citations81
US7396958B2Jul 8, 2008
Sulphonamide derivatives, their preparation and their therapeutic application
SANOFI AVENTIS14 citations81
US7129240B2Oct 31, 2006
1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
SANOFI AVENTIS3 citations62
US7202267B2Apr 10, 2007
Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
SANOFI AVENTIS4 citations61
US7425566B2Sep 16, 2008
1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
SANOFI AVENTIS0 citations52
US7297692B2Nov 20, 2007
1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
SANOFI AVENTIS0 citations52
US7910584B2Mar 22, 2011
3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
SANOFI AVENTIS0 citations41
US7488743B2Feb 10, 2009
Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
SANOFI AVENTIS0 citations41
SANOFI SYNTHELABO
8 patentsUS6090818AJul 18, 2000
Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
SANOFI SYNTHELABO90 citations97
US5994350ANov 30, 1999
3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
SANOFI SYNTHELABO63 citations96
US6313128B1Nov 6, 2001
Cosmetic composition containing a neuropeptide Y receptor antagonist
SANOFI SYNTHELABO64 citations93
US6864277B2Mar 8, 2005
1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
SANOFI SYNTHELABO32 citations92
US6730695B2May 4, 2004
1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors
SANOFI SYNTHELABO14 citations92
US6624164B2Sep 23, 2003
1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
SANOFI SYNTHELABO30 citations92
US6596732B2Jul 22, 2003
1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
SANOFI SYNTHELABO30 citations92
US6673790B1Jan 6, 2004
Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
SANOFI SYNTHELABO10 citations73
SANOFI SA
5 patentsUS6114336ASep 5, 2000
Cosmetic composition containing a neuropeptide Y receptor antagonist
SANOFI SA61 citations93
US5827853AOct 27, 1998
Cosmetic composition containing a neuropeptide Y receptor antagonist
SANOFI SA36 citations92
US5714497AFeb 3, 1998
Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
SANOFI SA21 citations91
US5674890AOct 7, 1997
Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
SANOFI SA6 citations72
US8362067B2Jan 29, 2013
3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof
SANOFI SA0 citations33